🇺🇸 FDA

Intelligence Platform

Patents

Browse 179 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9624283

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603945

Heparosan polymers and methods of making and using same for the enhancement of therapeutic

The Board of Regents of the University of Oklahoma · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603896

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9540337

Gamma-glutamyl transpeptidase inhibitors and methods of use

The Board of Regents of the University of Oklahoma · Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9527884

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein

The Board of Regents of the University of Oklahoma · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9504745

Compositions and methods for cancer treatment using targeted carbon nanotubes

The Board of Regents of the University of Oklahoma · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9393306

Singlet oxygen-labile linkers and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359196

Antiproliferative compositions comprising curcumin analogs and methods of producing and us

The Board of Regents of the University of Oklahoma · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303087

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and

The Board of Regents of the University of Oklahoma · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9228001

Mutants of cholesterol-dependent cytolysins and uses thereof

The Board of Regents of the University of Oklahoma · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9200024

Production of defined monodisperse heparosan polymers and unnatural polymers with polysacc

The Board of Regents of the University of Oklahoma · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9173839

Anionic lipids and lipid nano-structures and methods of producing and using same

The Board of Regents of the University of Oklahoma · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9096679

Peptide compounds and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034642

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986701

Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of pro

The Board of Regents of the University of Oklahoma · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980608

High molecular weight heparosan polymers and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8974810

Tissue graft compositions and methods for producing same

The Board of Regents of the University of Oklahoma · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8936941

Compositions useful for cancer detection and treatment, a cancer stem cell model, and meth

The Board of Regents of the University of Oklahoma · Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8933201

Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein

The Board of Regents of the University of Oklahoma · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859736

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and

The Board of Regents of the University of Oklahoma · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8740872

Magnetically-targeted treatment for cardiac disorders

The Board of Regents of the University of Oklahoma · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741937

Gamma glutamyl transpeptidase inhibitors and methods of use

The Board of Regents of the University of Oklahoma · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703200

Inhibition of neovascularization by cerium oxide nanoparticles

The Board of Regents of the University of Oklahoma · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8628917

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted